Search Results 831-840 of 19124 for creatinine

1. High-dose Prophylactic Gabapentin (HOPE) Vs. Placebo To Prevent Opioid Use For Oral Mucositis Pain During Concurrent Chemoradiation For Head And Neck Cancer - Mayo Clinic

   Creatinine ≤ 1.5 x upper limit of normal (ULN). Not pregnant and not nursing, because this study involves both radiation and chemotherapy. In addition, the ...

2. A Study To Evaluate Lumasiran In Patients With Advanced Primary Hyperoxaluria Type 1 - Mayo Clinic

   Estimated glomerular filtration rate (eGRF) ≤ 45 mL/min/1.73 m^2 for patients ≥ 12 months of age (< 12 months of age, must have serum creatinine considered ...

3. Risk-Based Therapy in Treating Younger Patients with Newly Diagnosed Liver Cancer - Mayo Clinic

   Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min/1.73 m^2 OR serum creatinine based on age/gender as follows: 1 month to ...

4. A Study of the Effect of Using MRI and Mammography Before Surgery in Patients with Stage I-II Breast Cancer - Mayo Clinic

   ... creatinine level obtained within 28 days prior to registration; Weight lower than that allowable by the MRI table. No prior MRI of study breast within the 12 ...

5. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   Serum creatinine ≤ 1.5 x ULN OR calculated creatinine clearance (CrCl) ... creatinine levels > 1.5 x ULN. In this protocol, cisplatin or carboplatin ...

6. Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma - Mayo Clinic

   Creatinine ≤ 1.5 x ULN; Creatinine clearance ≥ 50mL/min (Cockcroft-Gault calculation); Fasting serum cholesterol ≤ 300 mg/dL OR ≤ 7.75 mmol/L AND fasting ...

7. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Adequate biochemistry laboratory results (AST/SGOT and ALT/SGPT ≤ 3.0 x upper limit of normal; bilirubin ≤ 2.0 mg/dL; creatinine clearance of ≥ 40 mL/min).

8. A Study of X4P-001 in Patients with Advanced Renal Cell Carcinoma - Mayo Clinic

   Creatinine >2.0x ULN;; Serum aspartate transaminase (AST) >2.5x ULN;; Serum alanine transaminase (ALT) >2.5x ULN;; Total bilirubin >1.5x ULN (unless due to ...

9. Cardiac Vascular Reconstruction DynaCT for TAVI Procedures - Mayo Clinic

   Creatinine > 3.0 mg/dl; Lack of research consent. Lack of pre-procedure contrast enhanced Radiology cardiac CT. Participating Mayo Clinic locations. Study ...

10. E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS) - Mayo Clinic

    - Creatinine =< 1.5 x the upper limit of normal (ULN), or calculated creatinine clearance >= 50 mL/minute per the Cockcroft-Gault formula (obtained =< 15 ...